BIOSPECIFICS TECHNOLOGIES
BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren’s contracture and Peyronie’s disease. The company also develops XIAFLEX injectable collagenase for frozen shoulder, cellulite, human lipoma, canine lipoma, and uterine fibroid indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company was founded in 1957 and is headquartered in Lynbrook, New York.
BIOSPECIFICS TECHNOLOGIES
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
1957-01-01
Address:
Lynbrook, New York, United States
Country:
United States
Website Url:
http://www.biospecifics.com
Total Employee:
1+
Status:
Active
Contact:
516 5937039
Technology used in webpage:
SPF SSL By Default Content Delivery Network Google Universal Analytics Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare Cloudflare Hosting Cloudflare SSL
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.biospecifics.com
- Host name: 69.172.200.252
- IP address: 69.172.200.252
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioSpecifics Technologies"
BioSpecifics Technologies - Crunchbase Company Profile & Funding
BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the …See details»
BioSpecifics Technologies Corp. - AnnualReports.com
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development …See details»
BioSpecifics Technologies - Craft
Dec 17, 2020 BioSpecifics Technologies is a biopharmaceutical company which engages in …See details»
Endo Completes Acquisition of BioSpecifics - Dec 2, 2020
DUBLIN, Dec. 2, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced …See details»
Biospecifics Technologies - PitchBook
BioSpecifics Technologies Corp is a biopharmaceutical company that specializes in …See details»
BioSpecifics Technologies - Overview, News & Similar companies ...
Who is BioSpecifics Technologies. BioSpecifics Technologies Corp., a biopharmaceutical …See details»
BioSpecifics Technologies - Ownership and Business Overview
Oct 19, 2020 BioSpecifics Technologies is a life science company. Life Science M&A …See details»
Company BioSpecifics Technologies Corp. - MarketScreener.com
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development …See details»
BioSpecifics to be Acquired by Endo Pharmaceuticals - PR Newswire
Oct 19, 2020 BioSpecifics Technologies Corp. is a commercial-stage biopharmaceutical …See details»
BioSpecifics Technologies Corp. Company Profile & Data: stocks, …
The company has a development and license agreement with Endo Global Ventures. …See details»
BioSpecifics Technologies acquired by Endo Pharmaceuticals
Oct 19, 2020 BioSpecifics Technologies BioSpecifics is a biopharmaceutical company that …See details»
BioSpecifics to be Acquired by Endo Pharmaceuticals - Nasdaq
Oct 19, 2020 " BioSpecifics Technologies Corp. pioneered the development of collagenase …See details»
BioSpecifics Technologies Corp. - Dun & Bradstreet
Company Description: BioSpecifics Technologies specifically uses collagenase (an enzyme …See details»
BioSpecifics Announces Completion of Acquisition by Endo …
Dec 2, 2020 BioSpecifics Technologies Corp. is a commercial-stage biopharmaceutical …See details»
BioSpecifics Technologies Corp. - Drug pipelines, Patents, Clinical ...
He also served on the Boards of Directors at Biospecifics Technologies, Inc. until its acquisition …See details»
BioSpecifics - CoBee Company Profile & Funding Rounds
BioSpecifics is a New York-based biopharmaceutical company that develops injectable …See details»
BioSpecifics Technologies - Tech Stack, Apps, Patents & Trademarks
BioSpecifics is a biopharmaceutical company that has developed injectable collagenase for …See details»
Endo International agrees to acquire BioSpecifics Technologies for …
Oct 20, 2020 Endo International has agreed to acquire BioSpecifics Technologies in a cash …See details»
BioSpecifics’s Competitors, Revenue, Number of Employees
BioSpecifics’s Profile, Revenue and Employees. BioSpecifics is a New York-based …See details»
BioSpecifics Announces Completion of Acquisition by Endo ...
Dec 2, 2020 BioSpecifics Technologies Corp. is a commercial-stage biopharmaceutical …See details»